FSB Premier Wealth Management Inc. Has $1.79 Million Holdings in Elevance Health, Inc. $ELV

FSB Premier Wealth Management Inc. increased its holdings in shares of Elevance Health, Inc. (NYSE:ELV) by 41.1% during the third quarter, Holdings Channel.com reports. The fund owned 5,548 shares of the company’s stock after purchasing an additional 1,615 shares during the quarter. FSB Premier Wealth Management Inc.’s holdings in Elevance Health were worth $1,793,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the business. Investment House LLC acquired a new stake in shares of Elevance Health in the third quarter valued at approximately $969,000. Greatmark Investment Partners Inc. increased its stake in Elevance Health by 23.8% during the 3rd quarter. Greatmark Investment Partners Inc. now owns 35,483 shares of the company’s stock worth $11,465,000 after acquiring an additional 6,833 shares during the period. ARGA Investment Management LP acquired a new position in Elevance Health in the 3rd quarter valued at $85,779,000. Mn Services Vermogensbeheer B.V. raised its holdings in Elevance Health by 1.2% in the 3rd quarter. Mn Services Vermogensbeheer B.V. now owns 85,600 shares of the company’s stock valued at $27,659,000 after acquiring an additional 1,000 shares in the last quarter. Finally, Deseret Mutual Benefit Administrators lifted its position in shares of Elevance Health by 31.7% during the 3rd quarter. Deseret Mutual Benefit Administrators now owns 736 shares of the company’s stock valued at $238,000 after acquiring an additional 177 shares during the period. Institutional investors own 89.24% of the company’s stock.

Elevance Health Trading Down 0.4%

Shares of Elevance Health stock opened at $370.77 on Friday. The firm’s 50 day moving average is $349.17 and its 200 day moving average is $328.79. The firm has a market capitalization of $82.40 billion, a PE ratio of 15.16, a price-to-earnings-growth ratio of 1.91 and a beta of 0.51. Elevance Health, Inc. has a 1 year low of $273.71 and a 1 year high of $458.75. The company has a current ratio of 1.56, a quick ratio of 1.56 and a debt-to-equity ratio of 0.71.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on ELV shares. Barclays raised their price target on Elevance Health from $385.00 to $404.00 and gave the stock an “overweight” rating in a research report on Monday, January 5th. JPMorgan Chase & Co. raised their target price on shares of Elevance Health from $384.00 to $394.00 and gave the company an “overweight” rating in a report on Tuesday, October 28th. Bank of America upped their price target on shares of Elevance Health from $330.00 to $370.00 and gave the stock a “neutral” rating in a report on Friday, October 10th. Wolfe Research set a $425.00 price objective on shares of Elevance Health and gave the company an “outperform” rating in a research note on Thursday, January 8th. Finally, The Goldman Sachs Group initiated coverage on shares of Elevance Health in a research report on Tuesday, October 14th. They set a “neutral” rating and a $343.00 price objective for the company. Twelve equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $399.63.

Elevance Health Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.